Cryptocurrencies
Novo Nordisk’s CEO delivered a warning that sank its stock by 8%
Investor days are usually a chance for a company to reassure shareholders. Novo Nordisk (NVO) did the opposite on Monday, September 21. The Danish drugmaker behind Wegovy and Ozempic gathered analysts in London to explain Read more…